Ask AI
ProCE Banner Activity

IAS 2025: HIV Progress and Challenges in Canada and Globally

Clinical Thought

The number of new HIV diagnoses in Canada continues to grow year over year, but the caliber of research and passion demonstrated by all at IAS 2025 provide hope for the future of our HIV response. 

Released: August 07, 2025

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

IAS

ProCE Banner

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Disclosure

Primary Author

Alexander Wong, MD, FRCPC: consultant/advisor/speaker: Gilead, Merck, ViiV.